Market closed
Globus Medical/$GMED
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Globus Medical
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
Ticker
$GMED
Sector
Trading on
NYSE
Industry
Health Care Equipment & Supplies
Headquarters
Employees
5,300
Website
Globus Medical Metrics
BasicAdvanced
$10B
98.12
$0.75
1.19
-
Price and volume
Market cap
$10B
Beta
1.19
52-week high
$94.93
52-week low
$49.33
Average daily volume
1.4M
Financial strength
Current ratio
2.544
Quick ratio
1.716
Long term debt to equity
2.008
Total debt to equity
12.872
Interest coverage (TTM)
105.28%
Management effectiveness
Return on assets (TTM)
5.33%
Return on equity (TTM)
2.52%
Valuation
Price to earnings (TTM)
98.12
Price to revenue (TTM)
3.965
Price to book
2.42
Price to tangible book (TTM)
5.19
Price to free cash flow (TTM)
24.649
Growth
Revenue change (TTM)
60.62%
Earnings per share change (TTM)
-29.91%
3-year revenue growth (CAGR)
38.03%
3-year earnings per share growth (CAGR)
-19.54%
What the Analysts think about Globus Medical
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Globus Medical stock.
Globus Medical Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Globus Medical Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Globus Medical News
AllArticlesVideos
NEVRO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Nevro Corp. - NVRO
Business Wire·1 day ago
Globus Medical extends versatility of Advanced Materials Science™ anterior interbody portfolio with launch of COHERE™ ALIF Spacer and Modulus™ ALIF Blades
GlobeNewsWire·2 weeks ago
Globus Medical to feature ExcelsiusFlex™ for Total Knee Arthroplasty at the American Academy of Orthopedic Surgeons Annual Meeting
GlobeNewsWire·2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Globus Medical stock?
Globus Medical (GMED) has a market cap of $10B as of March 23, 2025.
What is the P/E ratio for Globus Medical stock?
The price to earnings (P/E) ratio for Globus Medical (GMED) stock is 98.12 as of March 23, 2025.
Does Globus Medical stock pay dividends?
No, Globus Medical (GMED) stock does not pay dividends to its shareholders as of March 23, 2025.
When is the next Globus Medical dividend payment date?
Globus Medical (GMED) stock does not pay dividends to its shareholders.
What is the beta indicator for Globus Medical?
Globus Medical (GMED) has a beta rating of 1.19. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.